位置:首页 > 蛋白库 > DOX1_ARATH
DOX1_ARATH
ID   DOX1_ARATH              Reviewed;         639 AA.
AC   Q9SGH6;
DT   28-NOV-2012, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2000, sequence version 1.
DT   03-AUG-2022, entry version 142.
DE   RecName: Full=Alpha-dioxygenase 1 {ECO:0000303|PubMed:12060227};
DE            Short=Alpha DOX1 {ECO:0000303|PubMed:12060227};
DE            EC=1.13.11.92 {ECO:0000269|PubMed:10455113};
DE   AltName: Full=Fatty acid dioxygenase AlphaDOX1 {ECO:0000305};
DE   AltName: Full=Pathogen-induced oxygenase {ECO:0000303|PubMed:10455113};
DE   AltName: Full=Plant alpha dioxygenase 1 {ECO:0000303|PubMed:15100225};
GN   Name=DOX1 {ECO:0000303|PubMed:12060227};
GN   Synonyms=DIOX1 {ECO:0000305}, PADOX-1 {ECO:0000303|PubMed:15100225},
GN   PIOX {ECO:0000303|PubMed:10455113};
GN   OrderedLocusNames=At3g01420 {ECO:0000312|Araport:AT3G01420};
GN   ORFNames=T13O15.6 {ECO:0000312|EMBL:AAF24612.1};
OS   Arabidopsis thaliana (Mouse-ear cress).
OC   Eukaryota; Viridiplantae; Streptophyta; Embryophyta; Tracheophyta;
OC   Spermatophyta; Magnoliopsida; eudicotyledons; Gunneridae; Pentapetalae;
OC   rosids; malvids; Brassicales; Brassicaceae; Camelineae; Arabidopsis.
OX   NCBI_TaxID=3702;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], FUNCTION, INDUCTION BY PATHOGENS, AND
RP   TISSUE SPECIFICITY.
RC   STRAIN=cv. Columbia;
RX   PubMed=12060227; DOI=10.1046/j.1365-313x.2002.01195.x;
RA   De Leon I.P., Sanz A., Hamberg M., Castresana C.;
RT   "Involvement of the Arabidopsis alpha-DOX1 fatty acid dioxygenase in
RT   protection against oxidative stress and cell death.";
RL   Plant J. 29:61-62(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=cv. Columbia;
RX   PubMed=11130713; DOI=10.1038/35048706;
RA   Salanoubat M., Lemcke K., Rieger M., Ansorge W., Unseld M., Fartmann B.,
RA   Valle G., Bloecker H., Perez-Alonso M., Obermaier B., Delseny M.,
RA   Boutry M., Grivell L.A., Mache R., Puigdomenech P., De Simone V.,
RA   Choisne N., Artiguenave F., Robert C., Brottier P., Wincker P.,
RA   Cattolico L., Weissenbach J., Saurin W., Quetier F., Schaefer M.,
RA   Mueller-Auer S., Gabel C., Fuchs M., Benes V., Wurmbach E., Drzonek H.,
RA   Erfle H., Jordan N., Bangert S., Wiedelmann R., Kranz H., Voss H.,
RA   Holland R., Brandt P., Nyakatura G., Vezzi A., D'Angelo M., Pallavicini A.,
RA   Toppo S., Simionati B., Conrad A., Hornischer K., Kauer G., Loehnert T.-H.,
RA   Nordsiek G., Reichelt J., Scharfe M., Schoen O., Bargues M., Terol J.,
RA   Climent J., Navarro P., Collado C., Perez-Perez A., Ottenwaelder B.,
RA   Duchemin D., Cooke R., Laudie M., Berger-Llauro C., Purnelle B., Masuy D.,
RA   de Haan M., Maarse A.C., Alcaraz J.-P., Cottet A., Casacuberta E.,
RA   Monfort A., Argiriou A., Flores M., Liguori R., Vitale D., Mannhaupt G.,
RA   Haase D., Schoof H., Rudd S., Zaccaria P., Mewes H.-W., Mayer K.F.X.,
RA   Kaul S., Town C.D., Koo H.L., Tallon L.J., Jenkins J., Rooney T., Rizzo M.,
RA   Walts A., Utterback T., Fujii C.Y., Shea T.P., Creasy T.H., Haas B.,
RA   Maiti R., Wu D., Peterson J., Van Aken S., Pai G., Militscher J.,
RA   Sellers P., Gill J.E., Feldblyum T.V., Preuss D., Lin X., Nierman W.C.,
RA   Salzberg S.L., White O., Venter J.C., Fraser C.M., Kaneko T., Nakamura Y.,
RA   Sato S., Kato T., Asamizu E., Sasamoto S., Kimura T., Idesawa K.,
RA   Kawashima K., Kishida Y., Kiyokawa C., Kohara M., Matsumoto M., Matsuno A.,
RA   Muraki A., Nakayama S., Nakazaki N., Shinpo S., Takeuchi C., Wada T.,
RA   Watanabe A., Yamada M., Yasuda M., Tabata S.;
RT   "Sequence and analysis of chromosome 3 of the plant Arabidopsis thaliana.";
RL   Nature 408:820-822(2000).
RN   [3]
RP   GENOME REANNOTATION.
RC   STRAIN=cv. Columbia;
RX   PubMed=27862469; DOI=10.1111/tpj.13415;
RA   Cheng C.Y., Krishnakumar V., Chan A.P., Thibaud-Nissen F., Schobel S.,
RA   Town C.D.;
RT   "Araport11: a complete reannotation of the Arabidopsis thaliana reference
RT   genome.";
RL   Plant J. 89:789-804(2017).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=cv. Columbia;
RX   PubMed=14593172; DOI=10.1126/science.1088305;
RA   Yamada K., Lim J., Dale J.M., Chen H., Shinn P., Palm C.J., Southwick A.M.,
RA   Wu H.C., Kim C.J., Nguyen M., Pham P.K., Cheuk R.F., Karlin-Newmann G.,
RA   Liu S.X., Lam B., Sakano H., Wu T., Yu G., Miranda M., Quach H.L.,
RA   Tripp M., Chang C.H., Lee J.M., Toriumi M.J., Chan M.M., Tang C.C.,
RA   Onodera C.S., Deng J.M., Akiyama K., Ansari Y., Arakawa T., Banh J.,
RA   Banno F., Bowser L., Brooks S.Y., Carninci P., Chao Q., Choy N., Enju A.,
RA   Goldsmith A.D., Gurjal M., Hansen N.F., Hayashizaki Y., Johnson-Hopson C.,
RA   Hsuan V.W., Iida K., Karnes M., Khan S., Koesema E., Ishida J., Jiang P.X.,
RA   Jones T., Kawai J., Kamiya A., Meyers C., Nakajima M., Narusaka M.,
RA   Seki M., Sakurai T., Satou M., Tamse R., Vaysberg M., Wallender E.K.,
RA   Wong C., Yamamura Y., Yuan S., Shinozaki K., Davis R.W., Theologis A.,
RA   Ecker J.R.;
RT   "Empirical analysis of transcriptional activity in the Arabidopsis
RT   genome.";
RL   Science 302:842-846(2003).
RN   [5]
RP   FUNCTION, CATALYTIC ACTIVITY, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=10455113; DOI=10.1074/jbc.274.35.24503;
RA   Hamberg M., Sanz A., Castresana C.;
RT   "alpha-oxidation of fatty acids in higher plants. Identification of a
RT   pathogen-inducible oxygenase (piox) as an alpha-dioxygenase and
RT   biosynthesis of 2-hydroperoxylinolenic acid.";
RL   J. Biol. Chem. 274:24503-24513(1999).
RN   [6]
RP   BIOPHYSICOCHEMICAL PROPERTIES, COFACTOR, AND MUTAGENESIS OF HIS-163;
RP   TYR-386; ARG-387 AND HIS-389.
RX   PubMed=15100225; DOI=10.1074/jbc.m401779200;
RA   Liu W., Rogge C.E., Bambai B., Palmer G., Tsai A.L., Kulmacz R.J.;
RT   "Characterization of the heme environment in Arabidopsis thaliana fatty
RT   acid alpha-dioxygenase-1.";
RL   J. Biol. Chem. 279:29805-29815(2004).
RN   [7]
RP   TISSUE SPECIFICITY.
RX   PubMed=17369372; DOI=10.1105/tpc.106.046052;
RA   Vellosillo T., Martinez M., Lopez M.A., Vicente J., Cascon T., Dolan L.,
RA   Hamberg M., Castresana C.;
RT   "Oxylipins produced by the 9-lipoxygenase pathway in Arabidopsis regulate
RT   lateral root development and defense responses through a specific signaling
RT   cascade.";
RL   Plant Cell 19:831-846(2007).
RN   [8]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=22199234; DOI=10.1093/mp/ssr105;
RA   Vicente J., Cascon T., Vicedo B., Garcia-Agustin P., Hamberg M.,
RA   Castresana C.;
RT   "Role of 9-lipoxygenase and alpha-dioxygenase oxylipin pathways as
RT   modulators of local and systemic defense.";
RL   Mol. Plant 5:914-928(2012).
RN   [9]
RP   SUBCELLULAR LOCATION.
RX   PubMed=24214535; DOI=10.1104/pp.113.230185;
RA   Shimada T.L., Takano Y., Shimada T., Fujiwara M., Fukao Y., Mori M.,
RA   Okazaki Y., Saito K., Sasaki R., Aoki K., Hara-Nishimura I.;
RT   "Leaf oil body functions as a subcellular factory for the production of a
RT   phytoalexin in Arabidopsis.";
RL   Plant Physiol. 164:105-118(2014).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (1.51 ANGSTROMS) IN COMPLEX WITH HEME AND CALCIUM
RP   ION, ACTIVE SITE, COFACTOR, BIOPHYSICOCHEMICAL PROPERTIES, SUBUNIT, AND
RP   MUTAGENESIS OF GLN-159; HIS-318; THR-323; TYR-386; ARG-565 AND ARG-566.
RX   PubMed=23373518; DOI=10.1021/bi400013k;
RA   Goulah C.C., Zhu G., Koszelak-Rosenblum M., Malkowski M.G.;
RT   "The crystal structure of alpha-dioxygenase provides insight into diversity
RT   in the cyclooxygenase-peroxidase superfamily.";
RL   Biochemistry 52:1364-1372(2013).
CC   -!- FUNCTION: Alpha-dioxygenase that catalyzes the primary oxygenation step
CC       of a variety of 14-20 carbon fatty acids, containing up to three
CC       unsaturated bonds, into their corresponding 2R-hydroperoxides
CC       (PubMed:12060227, PubMed:10455113). Involved in the production of
CC       oxylipins that function in cell signaling, wound healing, and
CC       protection from infection (PubMed:12060227, PubMed:10455113). Mediates
CC       protection against oxidative stress and cell death, probably by
CC       generating some lipid-derived molecules (PubMed:12060227). Promotes
CC       local and systemic plant defense in a salicylic acid (SA)-dependent
CC       manner, including the establishment of systemic acquired resistance
CC       (SAR) in response to incompatible interaction (PubMed:22199234).
CC       Involved in a negative regulation of abscisic acid (ABA)-mediated
CC       signaling pathway (PubMed:22199234). {ECO:0000269|PubMed:10455113,
CC       ECO:0000269|PubMed:12060227, ECO:0000269|PubMed:22199234}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 1,2-saturated fatty acid + O2 = a (2R)-2-hydroperoxy fatty
CC         acid; Xref=Rhea:RHEA:63508, ChEBI:CHEBI:15379, ChEBI:CHEBI:83955,
CC         ChEBI:CHEBI:147340; EC=1.13.11.92;
CC         Evidence={ECO:0000269|PubMed:10455113};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:63509;
CC         Evidence={ECO:0000269|PubMed:10455113};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(9Z,12Z,15Z)-octadecatrienoate + O2 = (R)-2-hydroperoxy-
CC         (9Z,12Z,15Z)-octadecatrienoate; Xref=Rhea:RHEA:16329,
CC         ChEBI:CHEBI:15379, ChEBI:CHEBI:32387, ChEBI:CHEBI:76161;
CC         EC=1.13.11.92; Evidence={ECO:0000269|PubMed:10455113};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:16330;
CC         Evidence={ECO:0000269|PubMed:10455113};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=hexadecanoate + O2 = (2R)-2-hydroperoxyhexadecanoate;
CC         Xref=Rhea:RHEA:63836, ChEBI:CHEBI:7896, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:149616; EC=1.13.11.92;
CC         Evidence={ECO:0000269|PubMed:10455113};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:63837;
CC         Evidence={ECO:0000269|PubMed:10455113};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(9Z,12Z)-octadecadienoate + O2 = (2R,9Z,12Z)-2-
CC         hydroperoxyoctadecadienoate; Xref=Rhea:RHEA:63860, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:30245, ChEBI:CHEBI:149618; EC=1.13.11.92;
CC         Evidence={ECO:0000269|PubMed:10455113};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:63861;
CC         Evidence={ECO:0000269|PubMed:10455113};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(9Z)-octadecenoate + O2 = (2R,9Z)-2-hydroperoxyoctadecenoate;
CC         Xref=Rhea:RHEA:63868, ChEBI:CHEBI:15379, ChEBI:CHEBI:30823,
CC         ChEBI:CHEBI:149623; EC=1.13.11.92;
CC         Evidence={ECO:0000269|PubMed:10455113};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:63869;
CC         Evidence={ECO:0000269|PubMed:10455113};
CC   -!- COFACTOR:
CC       Name=heme b; Xref=ChEBI:CHEBI:60344;
CC         Evidence={ECO:0000269|PubMed:15100225, ECO:0000269|PubMed:23373518};
CC       Note=Binds 1 heme b (iron(II)-protoporphyrin IX) group per subunit.
CC       {ECO:0000269|PubMed:15100225, ECO:0000269|PubMed:23373518};
CC   -!- COFACTOR:
CC       Name=Ca(2+); Xref=ChEBI:CHEBI:29108;
CC         Evidence={ECO:0000269|PubMed:23373518};
CC       Note=Binds 1 calcium ion per subunit. {ECO:0000269|PubMed:23373518};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=18 uM for linolenic acid (at pH 8 and 30 degrees Celsius)
CC         {ECO:0000269|PubMed:10455113};
CC         KM=17 uM for linoleic acid (at pH 8 and 30 degrees Celsius)
CC         {ECO:0000269|PubMed:10455113};
CC         KM=13 uM for oleic acid (at pH 8 and 30 degrees Celsius)
CC         {ECO:0000269|PubMed:10455113};
CC         KM=14 uM for oleic acid (at pH 7.8 and 30 degrees Celsius)
CC         {ECO:0000269|PubMed:15100225};
CC         KM=11 uM for palmitic acid (at pH 8 and 30 degrees Celsius)
CC         {ECO:0000269|PubMed:10455113};
CC         Vmax=119 nmol/min/mg enzyme with linolenic acid as substrate (at pH 8
CC         and 30 degrees Celsius) {ECO:0000269|PubMed:10455113};
CC         Vmax=111 nmol/min/mg enzyme with linoleic acid as substrate (at pH 8
CC         and 30 degrees Celsius) {ECO:0000269|PubMed:10455113};
CC         Vmax=91 nmol/min/mg enzyme with oleic acid as substrate (at pH 8 and
CC         30 degrees Celsius) {ECO:0000269|PubMed:10455113};
CC         Vmax=46 nmol/min/mg enzyme with palmitic acid as substrate (at pH 8
CC         and 30 degrees Celsius) {ECO:0000269|PubMed:10455113};
CC   -!- SUBUNIT: Forms monomers in solution. {ECO:0000269|PubMed:23373518}.
CC   -!- SUBCELLULAR LOCATION: Lipid droplet {ECO:0000269|PubMed:24214535}.
CC       Note=Localizes on the surface of leaf oil bodies.
CC       {ECO:0000269|PubMed:24214535}.
CC   -!- TISSUE SPECIFICITY: Expressed in roots (epiderm), mature flowers (e.g.
CC       anthers) and senescing leaves. {ECO:0000269|PubMed:12060227,
CC       ECO:0000269|PubMed:17369372}.
CC   -!- INDUCTION: Induced by salicylic acid (SA) and by some chemicals
CC       generating reactive oxygen species (ROS, e.g. nitric oxide (NO),
CC       intracellular superoxide and singlet oxygen) such as sodium
CC       nitropruside (SNP), paraquat and rose bengal (RB). Accumulates locally,
CC       at the infection site, in response to both incompatible and compatible
CC       bacterial pathogens (e.g. Pseudomonas syringae pv. tomato DC3000) in a
CC       SA-dependent manner, with a faster response during hypersensitive
CC       reactions. {ECO:0000269|PubMed:12060227}.
CC   -!- DISRUPTION PHENOTYPE: Slightly higher accumulation of Pseudomonas
CC       syringae pv. tomato DC3000 in infected leaves. Partially impaired
CC       systemic acquired resistance (SAR) in response to incompatible
CC       interaction. When associated with LOX1 disruption; hypersensitivity to
CC       the growth-inhibitory effect of abscisic acid (ABA) accompanied by an
CC       accumulation of ABA-inducible marker genes.
CC       {ECO:0000269|PubMed:22199234}.
CC   -!- SIMILARITY: Belongs to the peroxidase family. {ECO:0000255|PROSITE-
CC       ProRule:PRU00298}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF334402; AAL87742.1; -; Genomic_DNA.
DR   EMBL; AC010870; AAF24612.1; -; Genomic_DNA.
DR   EMBL; CP002686; AEE73664.1; -; Genomic_DNA.
DR   EMBL; AY042787; AAK68727.1; -; mRNA.
DR   EMBL; AY064666; AAL47373.1; -; mRNA.
DR   RefSeq; NP_186791.1; NM_111008.3.
DR   PDB; 4HHR; X-ray; 1.51 A; A=1-639.
DR   PDB; 4HHS; X-ray; 1.70 A; A=1-639.
DR   PDBsum; 4HHR; -.
DR   PDBsum; 4HHS; -.
DR   AlphaFoldDB; Q9SGH6; -.
DR   SMR; Q9SGH6; -.
DR   BioGRID; 6468; 2.
DR   STRING; 3702.AT3G01420.1; -.
DR   PeroxiBase; 3377; AtDiOx01.
DR   iPTMnet; Q9SGH6; -.
DR   PaxDb; Q9SGH6; -.
DR   PRIDE; Q9SGH6; -.
DR   ProteomicsDB; 222140; -.
DR   EnsemblPlants; AT3G01420.1; AT3G01420.1; AT3G01420.
DR   GeneID; 821135; -.
DR   Gramene; AT3G01420.1; AT3G01420.1; AT3G01420.
DR   KEGG; ath:AT3G01420; -.
DR   Araport; AT3G01420; -.
DR   TAIR; locus:2096697; AT3G01420.
DR   eggNOG; KOG2408; Eukaryota.
DR   HOGENOM; CLU_033051_0_0_1; -.
DR   InParanoid; Q9SGH6; -.
DR   OMA; AFAPWTK; -.
DR   OrthoDB; 276568at2759; -.
DR   PhylomeDB; Q9SGH6; -.
DR   BioCyc; ARA:AT3G01420-MON; -.
DR   BioCyc; MetaCyc:AT3G01420-MON; -.
DR   BRENDA; 1.13.11.92; 399.
DR   PRO; PR:Q9SGH6; -.
DR   Proteomes; UP000006548; Chromosome 3.
DR   ExpressionAtlas; Q9SGH6; baseline and differential.
DR   Genevisible; Q9SGH6; AT.
DR   GO; GO:0012511; C:monolayer-surrounded lipid storage body; IDA:TAIR.
DR   GO; GO:0020037; F:heme binding; IEA:InterPro.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0016702; F:oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen; IDA:TAIR.
DR   GO; GO:0004601; F:peroxidase activity; IEA:UniProtKB-KW.
DR   GO; GO:1902609; P:(R)-2-hydroxy-alpha-linolenic acid biosynthetic process; IMP:TAIR.
DR   GO; GO:0008219; P:cell death; IEP:TAIR.
DR   GO; GO:0071732; P:cellular response to nitric oxide; IEP:UniProtKB.
DR   GO; GO:0034614; P:cellular response to reactive oxygen species; IEP:UniProtKB.
DR   GO; GO:0071446; P:cellular response to salicylic acid stimulus; IEP:UniProtKB.
DR   GO; GO:0042742; P:defense response to bacterium; IEP:UniProtKB.
DR   GO; GO:0050832; P:defense response to fungus; IDA:TAIR.
DR   GO; GO:0001561; P:fatty acid alpha-oxidation; IDA:TAIR.
DR   GO; GO:0006629; P:lipid metabolic process; TAS:TAIR.
DR   GO; GO:0031408; P:oxylipin biosynthetic process; IEA:UniProtKB-KW.
DR   GO; GO:0009626; P:plant-type hypersensitive response; IEA:UniProtKB-KW.
DR   GO; GO:0009737; P:response to abscisic acid; IMP:UniProtKB.
DR   GO; GO:0006979; P:response to oxidative stress; IMP:TAIR.
DR   GO; GO:0009751; P:response to salicylic acid; IEP:TAIR.
DR   GO; GO:0009627; P:systemic acquired resistance; IMP:UniProtKB.
DR   CDD; cd09818; PIOX_like; 1.
DR   Gene3D; 1.10.640.10; -; 1.
DR   InterPro; IPR034815; A_dioxygenase.
DR   InterPro; IPR019791; Haem_peroxidase_animal.
DR   InterPro; IPR010255; Haem_peroxidase_sf.
DR   InterPro; IPR037120; Haem_peroxidase_sf_animal.
DR   Pfam; PF03098; An_peroxidase; 1.
DR   SUPFAM; SSF48113; SSF48113; 1.
DR   PROSITE; PS50292; PEROXIDASE_3; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Dioxygenase; Fatty acid biosynthesis; Fatty acid metabolism;
KW   Heme; Hypersensitive response; Iron; Lipid biosynthesis; Lipid droplet;
KW   Lipid metabolism; Metal-binding; Oxidoreductase; Oxylipin biosynthesis;
KW   Peroxidase; Plant defense; Reference proteome.
FT   CHAIN           1..639
FT                   /note="Alpha-dioxygenase 1"
FT                   /id="PRO_0000420284"
FT   ACT_SITE        163
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00298,
FT                   ECO:0000269|PubMed:23373518"
FT   BINDING         164
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000269|PubMed:23373518"
FT   BINDING         168
FT                   /ligand="heme b"
FT                   /ligand_id="ChEBI:CHEBI:60344"
FT                   /evidence="ECO:0000269|PubMed:23373518"
FT   BINDING         216
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000269|PubMed:23373518"
FT   BINDING         218
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000269|PubMed:23373518"
FT   BINDING         220
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000269|PubMed:23373518"
FT   BINDING         222
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000269|PubMed:23373518"
FT   BINDING         389
FT                   /ligand="heme b"
FT                   /ligand_id="ChEBI:CHEBI:60344"
FT                   /ligand_part="Fe"
FT                   /ligand_part_id="ChEBI:CHEBI:18248"
FT                   /note="axial binding residue"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00298,
FT                   ECO:0000269|PubMed:23373518"
FT   BINDING         486
FT                   /ligand="heme b"
FT                   /ligand_id="ChEBI:CHEBI:60344"
FT                   /evidence="ECO:0000269|PubMed:23373518"
FT   BINDING         490
FT                   /ligand="heme b"
FT                   /ligand_id="ChEBI:CHEBI:60344"
FT                   /evidence="ECO:0000269|PubMed:23373518"
FT   SITE            266
FT                   /note="Transition state stabilizer"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00298"
FT   MUTAGEN         159
FT                   /note="Q->N,S,V: Slightly reduces oxygenase activity."
FT                   /evidence="ECO:0000269|PubMed:23373518"
FT   MUTAGEN         163
FT                   /note="H->C: Reduces oxygenase activity 17-fold."
FT                   /evidence="ECO:0000269|PubMed:15100225"
FT   MUTAGEN         163
FT                   /note="H->M: Reduces oxygenase activity 6-fold."
FT                   /evidence="ECO:0000269|PubMed:15100225"
FT   MUTAGEN         163
FT                   /note="H->Q: Reduces oxygenase activity more than 100-
FT                   fold."
FT                   /evidence="ECO:0000269|PubMed:15100225"
FT   MUTAGEN         163
FT                   /note="H->Y: Reduces oxygenase activity 8-fold."
FT                   /evidence="ECO:0000269|PubMed:15100225"
FT   MUTAGEN         318
FT                   /note="H->A: Reduces oxygenase activity 14-fold."
FT                   /evidence="ECO:0000269|PubMed:23373518"
FT   MUTAGEN         318
FT                   /note="H->Q: Reduces oxygenase activity 4-fold."
FT                   /evidence="ECO:0000269|PubMed:23373518"
FT   MUTAGEN         323
FT                   /note="T->A: Reduces oxygenase activity 14-fold."
FT                   /evidence="ECO:0000269|PubMed:23373518"
FT   MUTAGEN         323
FT                   /note="T->L: Abolishes oxygenase activity."
FT                   /evidence="ECO:0000269|PubMed:23373518"
FT   MUTAGEN         386
FT                   /note="Y->F: Abolishes oxygenase activity."
FT                   /evidence="ECO:0000269|PubMed:23373518"
FT   MUTAGEN         386
FT                   /note="Y->F: Reduces oxygenase activity more than 100-
FT                   fold."
FT                   /evidence="ECO:0000269|PubMed:15100225"
FT   MUTAGEN         387
FT                   /note="R->H: No effect on oxygenase activity."
FT                   /evidence="ECO:0000269|PubMed:15100225"
FT   MUTAGEN         389
FT                   /note="H->C,M: Reduces oxygenase activity 13-fold."
FT                   /evidence="ECO:0000269|PubMed:15100225"
FT   MUTAGEN         565
FT                   /note="R->A: Slightly reduces oxygenase activity."
FT                   /evidence="ECO:0000269|PubMed:23373518"
FT   MUTAGEN         565
FT                   /note="R->K: Reduces oxygenase activity 3-fold."
FT                   /evidence="ECO:0000269|PubMed:23373518"
FT   MUTAGEN         565
FT                   /note="R->L: Reduces oxygenase activity 2-fold."
FT                   /evidence="ECO:0000269|PubMed:23373518"
FT   MUTAGEN         566
FT                   /note="R->A,L: Abolishes oxygenase activity."
FT                   /evidence="ECO:0000269|PubMed:23373518"
FT   MUTAGEN         566
FT                   /note="R->K: Reduces oxygenase activity 36-fold."
FT                   /evidence="ECO:0000269|PubMed:23373518"
FT   HELIX           1..12
FT                   /evidence="ECO:0007829|PDB:4HHR"
FT   HELIX           13..15
FT                   /evidence="ECO:0007829|PDB:4HHR"
FT   HELIX           18..20
FT                   /evidence="ECO:0007829|PDB:4HHR"
FT   HELIX           21..25
FT                   /evidence="ECO:0007829|PDB:4HHR"
FT   HELIX           29..43
FT                   /evidence="ECO:0007829|PDB:4HHR"
FT   HELIX           47..49
FT                   /evidence="ECO:0007829|PDB:4HHR"
FT   HELIX           52..69
FT                   /evidence="ECO:0007829|PDB:4HHR"
FT   HELIX           85..87
FT                   /evidence="ECO:0007829|PDB:4HHR"
FT   TURN            103..106
FT                   /evidence="ECO:0007829|PDB:4HHR"
FT   STRAND          113..116
FT                   /evidence="ECO:0007829|PDB:4HHR"
FT   HELIX           122..124
FT                   /evidence="ECO:0007829|PDB:4HHR"
FT   HELIX           130..137
FT                   /evidence="ECO:0007829|PDB:4HHR"
FT   STRAND          149..151
FT                   /evidence="ECO:0007829|PDB:4HHR"
FT   HELIX           152..165
FT                   /evidence="ECO:0007829|PDB:4HHR"
FT   STRAND          170..178
FT                   /evidence="ECO:0007829|PDB:4HHR"
FT   TURN            181..183
FT                   /evidence="ECO:0007829|PDB:4HHR"
FT   HELIX           184..186
FT                   /evidence="ECO:0007829|PDB:4HHR"
FT   STRAND          190..197
FT                   /evidence="ECO:0007829|PDB:4HHR"
FT   STRAND          205..207
FT                   /evidence="ECO:0007829|PDB:4HHR"
FT   STRAND          212..215
FT                   /evidence="ECO:0007829|PDB:4HHR"
FT   STRAND          217..220
FT                   /evidence="ECO:0007829|PDB:4HHR"
FT   HELIX           222..225
FT                   /evidence="ECO:0007829|PDB:4HHR"
FT   HELIX           229..235
FT                   /evidence="ECO:0007829|PDB:4HHR"
FT   TURN            247..249
FT                   /evidence="ECO:0007829|PDB:4HHR"
FT   HELIX           270..293
FT                   /evidence="ECO:0007829|PDB:4HHR"
FT   HELIX           299..320
FT                   /evidence="ECO:0007829|PDB:4HHR"
FT   HELIX           322..326
FT                   /evidence="ECO:0007829|PDB:4HHR"
FT   HELIX           330..341
FT                   /evidence="ECO:0007829|PDB:4HHR"
FT   HELIX           346..352
FT                   /evidence="ECO:0007829|PDB:4HHR"
FT   HELIX           358..361
FT                   /evidence="ECO:0007829|PDB:4HHR"
FT   HELIX           380..385
FT                   /evidence="ECO:0007829|PDB:4HHR"
FT   HELIX           389..391
FT                   /evidence="ECO:0007829|PDB:4HHR"
FT   STRAND          394..399
FT                   /evidence="ECO:0007829|PDB:4HHR"
FT   HELIX           407..409
FT                   /evidence="ECO:0007829|PDB:4HHR"
FT   STRAND          413..418
FT                   /evidence="ECO:0007829|PDB:4HHR"
FT   HELIX           419..422
FT                   /evidence="ECO:0007829|PDB:4HHR"
FT   HELIX           424..434
FT                   /evidence="ECO:0007829|PDB:4HHR"
FT   HELIX           436..444
FT                   /evidence="ECO:0007829|PDB:4HHR"
FT   HELIX           458..461
FT                   /evidence="ECO:0007829|PDB:4HHR"
FT   HELIX           479..489
FT                   /evidence="ECO:0007829|PDB:4HHR"
FT   HELIX           495..501
FT                   /evidence="ECO:0007829|PDB:4HHR"
FT   HELIX           510..512
FT                   /evidence="ECO:0007829|PDB:4HHR"
FT   HELIX           517..526
FT                   /evidence="ECO:0007829|PDB:4HHR"
FT   TURN            527..529
FT                   /evidence="ECO:0007829|PDB:4HHR"
FT   TURN            531..533
FT                   /evidence="ECO:0007829|PDB:4HHR"
FT   HELIX           536..542
FT                   /evidence="ECO:0007829|PDB:4HHR"
FT   STRAND          549..551
FT                   /evidence="ECO:0007829|PDB:4HHR"
FT   HELIX           553..568
FT                   /evidence="ECO:0007829|PDB:4HHR"
FT   HELIX           571..573
FT                   /evidence="ECO:0007829|PDB:4HHR"
FT   TURN            574..576
FT                   /evidence="ECO:0007829|PDB:4HHR"
FT   HELIX           579..582
FT                   /evidence="ECO:0007829|PDB:4HHR"
FT   HELIX           584..592
FT                   /evidence="ECO:0007829|PDB:4HHR"
FT   HELIX           596..603
FT                   /evidence="ECO:0007829|PDB:4HHR"
FT   HELIX           607..611
FT                   /evidence="ECO:0007829|PDB:4HHR"
FT   STRAND          614..616
FT                   /evidence="ECO:0007829|PDB:4HHR"
FT   HELIX           633..635
FT                   /evidence="ECO:0007829|PDB:4HHR"
SQ   SEQUENCE   639 AA;  73158 MW;  9AB1700BBF353E9E CRC64;
     MKVITSLISS ILLKFIHKDF HEIYARMSLL DRFLLLIVHG VDKMVPWHKL PVFLGLTYLE
     VRRHLHQQYN LLNVGQTPTG IRFDPANYPY RTADGKFNDP FNEGVGSQNS FFGRNCPPVD
     QKSKLRRPDP MVVATKLLGR KKFIDTGKQF NMIAASWIQF MIHDWIDHLE DTHQIELVAP
     KEVASKCPLS SFRFLKTKEV PTGFFEIKTG SQNIRTPWWD SSVIYGSNSK TLDRVRTYKD
     GKLKISEETG LLLHDEDGLA ISGDIRNSWA GVSALQALFI KEHNAVCDAL KDEDDDLEDE
     DLYRYARLVT SAVVAKIHTI DWTVQLLKTD TLLAGMRANW YGLLGKKFKD SFGHAGSSIL
     GGVVGMKKPQ NHGVPYSLTE DFTSVYRMHS LLPDQLHILD IDDVPGTNKS LPLIQEISMR
     DLIGRKGEET MSHIGFTKLM VSMGHQASGA LELMNYPMWL RDIVPHDPNG QARPDHVDLA
     ALEIYRDRER SVPRYNEFRR SMFMIPITKW EDLTEDEEAI EVLDDVYDGD VEELDLLVGL
     MAEKKIKGFA ISETAFYIFL IMATRRLEAD RFFTSDFNET IYTKKGLEWV NTTESLKDVI
     DRHYPDMTDK WMNSESAFSV WDSPPLTKNP IPLYLRIPS
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024